EGFR and colorectal adenoma: More interestingly, combination treatment of APCmin/+ mice using AMI-1 and cetuximab, a therapeutic EGFR monoclonal antibody [57], showed significant synergy to reduce the formation of colorectal adenomas in mice (Additional file 1: Fig. S9).